IDXX Overzicht aandelen
IDEXX Laboratories, Inc. ontwikkelt, produceert en distribueert producten voor met name de veterinaire huisdieren-, vee- en pluimvee-, zuivel- en watertestmarkten in Afrika, Azië-Pacific, Canada, Europa en Latijns-Amerika.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 2/6 |
| Prestaties in het verleden | 3/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 0/6 |
Beloningen
Risicoanalyse
IDXX onze risicocontroles hebben doorstaan.
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
IDEXX Laboratories, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$433.28 |
| 52 Week Hoogtepunt | US$583.39 |
| 52 Week Laag | US$404.74 |
| Bèta | 1.36 |
| 11 maand verandering | -8.72% |
| 3 maanden verandering | -10.26% |
| 1 Jaar Verandering | 1.06% |
| 33 jaar verandering | -31.03% |
| 5 jaar verandering | 66.79% |
| Verandering sinds IPO | 45,734.60% |
Recent nieuws en updates
Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects
Oct 28
Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 15We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
Sep 18A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Sep 05Recent updates
Investors Appear Satisfied With IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Prospects
Oct 28Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 15We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
Sep 18A Look At The Intrinsic Value Of IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Sep 05What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?
Aug 20IDEXX Laboratories Q2: Headwinds From Low U.S. Clinical Visits
Aug 12A Look Into IDEXX Laboratories' (NASDAQ:IDXX) Impressive Returns On Capital
Jul 02Looking For Fast Growth In Healthcare? IDEXX Has You Covered
Jun 28Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jun 04Should You Think About Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX) Now?
May 21IDEXX Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
May 03What IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) P/E Is Not Telling You
Apr 27IDEXX Laboratories (NASDAQ:IDXX) Has A Rock Solid Balance Sheet
Apr 11IDEXX: Strong Recurring Revenues From Consumables, Software But Overvalued (Rating Downgrade)
Apr 08Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jan 30IDEXX Laboratories: Valuation Rerating Doesn't Seem Justified
Jan 16Here's Why IDEXX Laboratories (NASDAQ:IDXX) Has Caught The Eye Of Investors
Jan 15IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Shareholders Might Be Looking For Exit
Dec 31IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly
Dec 15Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Oct 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching
Oct 10Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Sep 07Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jul 04These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
May 31At US$484, Is IDEXX Laboratories, Inc. (NASDAQ:IDXX) Worth Looking At Closely?
Apr 05Here's Why IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt Responsibly
Feb 22Why IDEXX Laboratories, Inc. (NASDAQ:IDXX) Could Be Worth Watching
Jan 05Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?
Nov 24When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Sep 20IDEXX Laboratories: Outstanding Business, But Valuation Is Key
Aug 15These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well
Aug 15IDEXX Laboratories Stock Is Very Expensive
Aug 08IDEXX Laboratories Non-GAAP EPS of $1.58 misses by $0.05, revenue of $860.55M misses by $1.57M
Aug 02Are IDEXX Laboratories, Inc. (NASDAQ:IDXX) Investors Paying Above The Intrinsic Value?
Jul 26Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Might Deserve Your Attention Today
Jul 12Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?
Jun 16IDEXX Laboratories: Great Business, But Still Overvalued
May 25We Think IDEXX Laboratories (NASDAQ:IDXX) Can Manage Its Debt With Ease
May 06Rendement voor aandeelhouders
| IDXX | US Medical Equipment | US Markt | |
|---|---|---|---|
| 7D | 3.8% | 1.6% | 5.0% |
| 1Y | 1.1% | 31.5% | 36.1% |
Rendement versus industrie: IDXX presteerde slechter dan de US Medical Equipment -sector, die het afgelopen jaar een rendement van 31.5 % opleverde.
Rendement versus markt: IDXX presteerde slechter dan US Market, dat het afgelopen jaar een rendement van 36.1 % opleverde.
Prijsvolatiliteit
| IDXX volatility | |
|---|---|
| IDXX Average Weekly Movement | 4.0% |
| Medical Equipment Industry Average Movement | 7.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.9% |
Stabiele aandelenkoers: IDXX heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van IDXX is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1983 | 11,000 | Jay Mazelsky | www.idexx.com |
IDEXX Laboratories, Inc. ontwikkelt, produceert en distribueert producten voor met name de veterinaire huisdieren-, vee- en pluimvee-, zuivel- en watertestmarkten in Afrika, Azië-Pacific, Canada, Europa en Latijns-Amerika. Het bedrijf is actief in drie segmenten: Companion Animal Group; Waterkwaliteitsproducten; en Vee, Pluimvee en Zuivel. Het bedrijf biedt ook point-of-care veterinaire diagnostische producten, waaronder instrumenten, verbruiksartikelen en snelle testkits; veterinaire referentielaboratoriumdiagnostiek en adviesdiensten; praktijkmanagement en diagnostische beeldvormingssystemen en -diensten voor dierenartsen; en gezondheidsmonitoring, biologische materiaaltesten en laboratoriumdiagnostische instrumenten en diensten voor biomedische onderzoeksgemeenschappen.
IDEXX Laboratories, Inc. Samenvatting
| IDXX fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$35.46b |
| Inkomsten(TTM) | US$866.24m |
| Inkomsten(TTM) | US$3.84b |
41.0x
Koers/Winstverhouding9.2x
P/S-verhoudingIs IDXX overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| IDXX resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$3.84b |
| Kosten van inkomsten | US$1.51b |
| Brutowinst | US$2.33b |
| Overige uitgaven | US$1.47b |
| Inkomsten | US$866.24m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 10.58 |
| Brutomarge | 60.72% |
| Nettowinstmarge | 22.53% |
| Schuld/Eigen Vermogen Verhouding | 54.0% |
Hoe presteerde IDXX op de lange termijn?
Bekijk historische prestaties en vergelijking